CRBU Caribou Biosciences, Inc. - Common Stock
NASDAQ · Biotechnology · Voir sur SEC EDGAR ↗ 10-K/10-Q Aoû 13, 2026
$0,46
· % de la fourchette 52 sem.
· au-dessus du plus bas
· vers le haut
$0,44Bas 52 semaines
$3,54Haut 52 semaines
Capitalisation Boursière (MRQ)
$49M
P/E (TTM)
-0.4
BPA (TTM)
$-1.08
Revenu (TTM)
$10M
vos badges
Fourchette 52 semaines
$0–$4
Note des analystes
BUY
Objectif de cours
$6
P/E
-0.4
ROE
-78.3%
Marge nette
-1030.4%
Votre barre de badges est vide — épinglez une métrique n'importe où sur cette page.
CRBU Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$0.46
Capitalisation Boursière (MRQ)
$49M
P/E (TTM)
-0.4
BPA (TTM)
$-1.08
Revenu (TTM)
$10M
ROE (TTM)
-78.3%
Fourchette 52 semaines
$0–$4
CRBU Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
fourchette
barres
La granularité des barres s'adapte à la période sélectionnée — survolez le graphique pour voir l'ouverture/le maximum/le minimum/la clôture d'une barre.
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenu$11M2019-12-31 → 2025-12-31
BPA$-1.592021-12-31 → 2025-12-31
Flux de trésorerie libre$-112M2021-12-31 → 2025-12-31
Marge nette-1030.4%2021-12-31 → 2025-12-31
Valorisation et Ratios
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
| Métrique | Tendance sur 5 ans | CRBU | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -0.4moyenne 5 ans ≈-3.4 | ≈-3.4 | · | · | |
| P/S (TTM) | 4.9moyenne 5 ans ≈33.1 | ≈33.1 | 20.5 | Juste valeur | |
| P/B (MRQ) | 0.5moyenne 5 ans ≈1.4 | ≈1.4 | 3.3 | Sous-évalué | |
| Cours / FCF (TTM) | -0.5moyenne 5 ans ≈-7.5 | ≈-7.5 | · | · | |
| Cours / Flux de trésorerie (TTM) | -0.5moyenne 5 ans ≈-8.0 | ≈-8.0 | · | · | |
| Price / Tangible Book (Cours / Actif net tangible) | 0.4moyenne 5 ans ≈1.4 | ≈1.4 | · | · |
La médiane des pairs est calculée sur une base standardisée par métrique et peut ne pas toujours correspondre à la base TTM/MRQ indiquée pour cette action.
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
| Métrique | Tendance sur 5 ans | CRBU | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Marge d'exploitation (TTM) | -1090.9%moyenne 5 ans ≈-959.8% | ≈-959.8% | -368.4% | Faible | |
| Marge EBITDA (TTM) | -1065.1%moyenne 5 ans ≈-939.0% | ≈-939.0% | -368.4% | Faible | |
| Pretax Margin (Marge avant impôts) | -1332.3%moyenne 5 ans ≈-906.2% | ≈-906.2% | -1163.4% | En ligne | |
| Marge nette (TTM) | -1030.4%moyenne 5 ans ≈-906.1% | ≈-906.1% | -320.2% | Faible | |
| ROA (TTM) | -56.9%moyenne 5 ans ≈-35.7% | ≈-35.7% | -60.6% | En ligne | |
| ROE (TTM) | -78.3%moyenne 5 ans ≈-46.8% | ≈-46.8% | -46.7% | Faible | |
| ROIC | -121.0%moyenne 5 ans ≈-54.2% | ≈-54.2% | -103.1% | Faible |
Santé financière Dette, liquidité, solvabilité — solidité du bilan
| Métrique | Tendance sur 5 ans | CRBU | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Ratio de liquidité (MRQ) | 6.5moyenne 5 ans ≈9.8 | ≈9.8 | 5.0 | Liquidité solide | |
| Quick Ratio (Ratio de liquidité réduite) | 0.5moyenne 5 ans ≈2.9 | ≈2.9 | 3.9 | Faible liquidité |
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
| Métrique | Tendance sur 5 ans | CRBU | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Revenue YoY (Chiffre d'affaires YoY) | 11.7%moyenne 5 ans ≈22.3% | ≈22.3% | · | · | |
| Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans) | -7.0%moyenne 5 ans ≈11.7% | ≈11.7% | · | · | |
| Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans) | -2.0% | · | · | · |
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
| Métrique | Tendance sur 5 ans | CRBU | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Asset Turnover (Rotation des actifs) | 0.0moyenne 5 ans ≈0.0 | ≈0.0 | 0.1 | Inférieur à la moyenne | |
| Receivables Turnover (Rotation des créances) | 66.8moyenne 5 ans ≈69.5 | ≈69.5 | 6.2 | Premier rang | |
| Revenue / Employee (Chiffre d'affaires annuel ÷ employés (effectif déclaré, yfinance). Dérivé — pas un concept SEC-XBRL stocké.) | ≈$115.0K | · | · | · |
valeur · ≈ moyenne 5 ans · médiane du secteur · verdict par rapport à la médiane
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
5.8%
Prochain rapport
Nov 09, 2026
| Période | Rapport | EPS Actual | BPA est. | Surprise |
|---|---|---|---|---|
| 30 juin 2026 | Aoû 13, 2026 | $-0.24 | $-0.32 | 25.7% |
| 31 mars 2026 | $-0.26 | $-0.32 | 19.8% | |
| 31 décembre 2025 | $-0.28 | $-0.32 | 11.4% | |
| 30 septembre 2025 | $-0.30 | $-0.37 | 18.4% | |
| 30 juin 2025 | $-0.58 | $-0.40 | -45.1% | |
| 31 mars 2025 | $-0.43 | $-0.45 | 4.7% |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $11M | $10M | $34M | $14M | $10M | $12M | |
| R&D Expense | $109M | $130M | $112M | $82M | $52M | $34M | |
| SG&A Expense | $38M | $46M | $38M | $38M | $24M | $14M | |
| Operating Expenses | $160M | $177M | $151M | $120M | $77M | $48M | |
| Operating Income | $-148M | $-167M | $-116M | $-106M | $-67M | $-36M | |
| Interest Expense | · | · | · | · | $8.0K | $20.0K | |
| Other Non-op | $-331.0K | $18M | $14M | $7M | $377.0K | $-3.0K | |
| Pretax Income | $-149M | $-149M | $-102M | $-99M | $-67M | $-36M | |
| Income Tax | $-550.0K | $-9.0K | $193.0K | $70.0K | $321.0K | $-2M | |
| Net Income | $-148M | $-149M | $-102M | $-99M | $-67M | $-34M | |
| EPS (Basic) | $-1.59 | $-1.65 | $-1.38 | $-1.64 | $-2.11 | · | |
| EPS (Diluted) | $-1.59 | $-1.65 | $-1.38 | $-1.64 | $-2.11 | · | |
| Shares (Basic) | 93,389,283 | 90,317,925 | 73,807,597 | 60,801,133 | 31,663,243 | · | |
| Shares (Diluted) | 93,389,283 | 90,317,925 | 73,807,597 | 60,801,133 | 31,663,243 | · | |
| EBITDA | $-145M | $-163M | $-113M | $-105M | $-66M | · |
Bilan
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $12M | $16M | $51M | $58M | $240M | $16M | |
| Short-term Investments | · | · | · | · | $135M | $0 | |
| Receivables | $69.0K | $265.0K | $148.0K | $202.0K | $1M | $150.0K | |
| Prepaid Expense | $3M | $7M | $6M | $8M | $7M | $3M | |
| Current Assets | $145M | $219M | $339M | $260M | $391M | $24M | |
| PP&E (Net) | $7M | $19M | $18M | $11M | $5M | $4M | |
| PP&E (Gross) | $20M | $32M | $27M | $16M | $9M | $7M | |
| Accum. Depreciation | $14M | $13M | $9M | $6M | $4M | $3M | |
| Other Non-current Assets | $2M | $6M | $2M | $2M | $975.0K | $612.0K | |
| Total Assets | $175M | $313M | $432M | $374M | $442M | $36M | |
| Accounts Payable | $6M | $2M | $3M | $1M | $4M | $3M | |
| Accrued Liabilities | $17M | $24M | $21M | $16M | $13M | $9M | |
| Current Liabilities | $25M | $31M | $28M | $28M | $26M | $12M | |
| Capital Leases | $26M | $25M | $26M | $27M | $0 | · | |
| Deferred Tax | $0 | $548.0K | $557.0K | $381.0K | $476.0K | $155.0K | |
| Total Liabilities | $53M | $60M | $64M | $73M | $55M | $18M | |
| Common Stock | $9.0K | $9.0K | $8.0K | $6.0K | $6.0K | $1.0K | |
| Paid-in Capital | $719M | $701M | $668M | $500M | $486M | $7M | |
| Retained Earnings | $-597M | $-448M | $-299M | $-197M | $-98M | $-31M | |
| AOCI | $103.0K | $255.0K | $30.0K | $-2M | $-135.0K | $0 | |
| Stockholders' Equity | $122M | $253M | $368M | $301M | $388M | $-23M | |
| Liabilities + Equity | $175M | $313M | $432M | $374M | $442M | $36M | |
| Shares Outstanding | 95,143,690 | 92,378,577 | 88,448,948 | 61,029,184 | 60,263,158 | 9,710,829 |
Flux de trésorerie
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $4M | $4M | $4M | $2M | $984.0K | $900.0K | |
| Stock-based Comp | $13M | $17M | $14M | $12M | $3M | $1M | |
| Deferred Tax | $-551.0K | $-10.0K | $178.0K | $-95.0K | $320.0K | $-919.0K | |
| Other Non-cash | $21M | $-10M | $-9M | $-5M | $30M | · | |
| Operating Cash Flow | $-111M | $-138M | $-93M | $-91M | $-33M | $-33M | |
| CapEx | $1M | $5M | $12M | $6M | $2M | $317.0K | |
| Investing Cash Flow | $102M | $87M | $-68M | $-93M | $-176M | $6M | |
| Stock Issued | $4M | $15M | $1M | $0 | · | · | |
| Net Stock Activity | $4M | $15M | $1M | · | · | · | |
| Financing Cash Flow | $5M | $17M | $154M | $2M | $433M | $2M | |
| Net Change in Cash | $-4M | $-35M | $-7M | $-182M | $225M | $-25M | |
| Taxes Paid | · | $0 | $170.0K | $0 | $11.0K | $21.0K | |
| Free Cash Flow | $-112M | $-143M | $-105M | $-97M | $-35M | · | |
| Levered FCF | · | · | · | · | $-35M | · |
Rentabilité
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -1329.4% | -1667.2% | -336.6% | -768.2% | -697.8% | · | |
| Net Margin | -1327.4% | -1491.9% | -296.1% | -717.8% | -697.3% | · | |
| Pretax Margin | -1332.3% | -1492.0% | -295.5% | -717.3% | -693.9% | · | |
| EBITDA Margin | -1296.7% | -1627.9% | -326.4% | -756.5% | -687.6% | · | |
| ROA | -60.6% | -40.0% | -25.3% | -24.4% | -28.0% | · | |
| ROE | -102.8% | -55.8% | -26.6% | -31.8% | -16.9% | · | |
| ROIC | -121.0% | -65.9% | -31.6% | -35.4% | -17.3% | · |
Liquidité et Solvabilité
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 5.7 | 7.2 | 12.0 | 9.3 | 15.1 | · | |
| Quick Ratio | 0.5 | 0.5 | 1.8 | 2.1 | 9.4 | · | |
| Interest Coverage | · | · | · | · | -8372.4 | · |
Efficacité
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | · | |
| Receivables Turnover | 66.8 | 48.4 | 197.0 | 20.4 | 14.7 | · |
Par action
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.28 | $2.74 | $4.17 | $4.93 | $6.44 | · | |
| Revenue / Share | $0.12 | $0.11 | $0.47 | $0.23 | · | · | |
| Cash Flow / Share | $-1.19 | $-1.53 | $-1.26 | $-1.50 | · | · | |
| Cash / Share | $0.13 | $0.18 | $0.58 | $0.96 | $3.99 | · | |
| EPS (TTM) | $-1.59 | $-1.65 | $-1.38 | $-1.64 | $-2.11 | · |
Taux de croissance
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.7% | -71.0% | 148.9% | 44.3% | -22.4% | · | |
| Revenue CAGR 3Y | -7.0% | 1.4% | 40.8% | · | · | · | |
| Revenue CAGR 5Y | -2.0% | · | · | · | · | · |
Valorisation (TTM)
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $11M | $10M | $34M | $14M | $10M | · | |
| Net Income TTM | $-148M | $-149M | $-102M | $-99M | $-67M | · | |
| Market Cap | $151M | $147M | $507M | $383M | $909M | · | |
| P/E | -1.0 | -1.0 | -4.2 | -3.8 | -7.2 | · | |
| P/S | 13.6 | 14.7 | 14.7 | 27.7 | 94.7 | · | |
| P/B | 1.2 | 0.6 | 1.4 | 1.3 | 2.3 | · | |
| P / Tangible Book | 1.2 | 0.6 | 1.4 | 1.3 | 2.3 | · | |
| P / Cash Flow | -1.4 | -1.1 | -5.4 | -4.2 | -28.0 | · | |
| P / FCF | -1.3 | -1.0 | -4.8 | -3.9 | -26.3 | · | |
| Earnings Yield | -100.0% | -103.8% | -24.1% | -26.1% | -14.0% | · |
Compte de résultat
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | $2M | $4M | $2M | $3M | $2M | $2M | $2M | $3M | $2M | $4M | $24M | $4M | $4M | $4M | $3M | |
| R&D Expense | $19M | $21M | $24M | $22M | $28M | $36M | $30M | $30M | $35M | $34M | $31M | $29M | $27M | $26M | $26M | $20M | |
| SG&A Expense | $8M | $8M | $9M | $9M | $10M | $10M | $10M | $10M | $11M | $15M | $10M | $10M | $10M | $9M | $9M | $10M | |
| Operating Expenses | $27M | $29M | $32M | $32M | $50M | $45M | $41M | $40M | $47M | $48M | $41M | $38M | $37M | $35M | $34M | $30M | |
| Operating Income | $-25M | $-26M | $-28M | $-29M | $-48M | $-43M | $-39M | $-38M | $-44M | $-46M | $-37M | $-15M | $-33M | $-31M | $-31M | $-27M | |
| Other Non-op | $1M | $1M | $1M | $2M | $-7M | $3M | $3M | $4M | $6M | $5M | $3M | $5M | $3M | $3M | $4M | $-110.0K | |
| Income Tax | · | $0 | $-550.0K | $0 | · | $0 | $-9.0K | $0 | $0 | $0 | $193.0K | $0 | $0 | $0 | $70.0K | $0 | |
| Net Income | $-24M | $-25M | $-26M | $-28M | $-54M | $-40M | $-35M | $-35M | $-38M | $-41M | $-35M | $-10M | $-30M | $-28M | $-27M | $-27M | |
| EPS (Basic) | $-0.24 | $-0.26 | $-0.28 | $-0.30 | $-0.58 | $-0.43 | $-0.39 | $-0.38 | $-0.42 | $-0.46 | $-0.32 | $-0.12 | $-0.48 | $-0.46 | $-0.44 | $-0.44 | |
| EPS (Diluted) | $-0.24 | $-0.26 | $-0.28 | $-0.30 | $-0.58 | $-0.43 | $-0.39 | $-0.38 | $-0.42 | $-0.46 | $-0.32 | $-0.12 | $-0.48 | $-0.46 | $-0.44 | $-0.44 | |
| Shares (Basic) | 100,985,698 | 95,861,716 | · | 93,293,099 | 93,028,698 | 92,679,493 | · | 90,455,900 | 90,340,932 | 89,302,937 | · | 83,783,992 | 61,417,934 | 61,186,514 | · | 60,886,921 | |
| Shares (Diluted) | 100,985,698 | 95,861,716 | · | 93,293,099 | 93,028,698 | 92,679,493 | · | 90,455,900 | 90,340,932 | 89,302,937 | · | 83,783,992 | 61,417,934 | 61,186,514 | · | 60,886,921 | |
| EBITDA | $-25M | $-26M | · | $-29M | $-48M | $-42M | · | $-38M | $-44M | $-45M | · | $-15M | · | · | · | $-27M |
Bilan
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $26M | $12M | $12M | $11M | $25M | $29M | $16M | $32M | $38M | $49M | $51M | $104M | $66M | $53M | $58M | $82M | |
| Receivables | $203.0K | $227.0K | $69.0K | $242.0K | $71.0K | $88.0K | $265.0K | $184.0K | $215.0K | $917.0K | $148.0K | $1M | $766.0K | $2M | $202.0K | $397.0K | |
| Prepaid Expense | $2M | $2M | $3M | $5M | $6M | $6M | $7M | $7M | $6M | $7M | $6M | $7M | $6M | $6M | $8M | $9M | |
| Current Assets | $117M | $122M | $145M | $156M | $193M | $217M | $219M | $237M | $271M | $305M | $339M | $351M | $269M | $239M | $260M | $307M | |
| PP&E (Net) | $5M | $6M | $7M | $8M | $8M | $19M | $19M | $20M | $20M | $19M | $18M | $17M | $15M | $13M | $11M | $9M | |
| PP&E (Gross) | $20M | $20M | $20M | $20M | $20M | $33M | $32M | $31M | $31M | $29M | $27M | $25M | $22M | $19M | $16M | $14M | |
| Accum. Depreciation | $15M | $14M | $14M | $13M | $12M | $14M | $13M | $12M | $11M | $10M | $9M | $8M | $7M | $6M | $6M | $5M | |
| Other Non-current Assets | $2M | $2M | $2M | $4M | $4M | $5M | $6M | $5M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $1M | |
| Total Assets | $143M | $149M | $175M | $195M | $221M | $274M | $313M | $344M | $373M | $407M | $432M | $458M | $350M | $347M | $374M | $399M | |
| Accounts Payable | $3M | $4M | $6M | $4M | $3M | $4M | $2M | $3M | $3M | $6M | $3M | $2M | $4M | $3M | $1M | $1M | |
| Accrued Liabilities | $13M | $14M | $17M | $19M | $21M | $20M | $24M | $25M | $24M | $19M | $21M | $18M | $16M | $13M | $16M | $15M | |
| Current Liabilities | $18M | $20M | $25M | $28M | $29M | $28M | $31M | $32M | $31M | $29M | $28M | $25M | $34M | $27M | $28M | $29M | |
| Capital Leases | $25M | $26M | $26M | $23M | $24M | $24M | $25M | $25M | $26M | $26M | $26M | $26M | $26M | $26M | $27M | $27M | |
| Deferred Tax | · | · | $0 | $548.0K | $548.0K | $548.0K | $548.0K | $557.0K | $557.0K | $556.0K | $557.0K | $381.0K | $380.0K | $382.0K | $381.0K | $475.0K | |
| Total Liabilities | $45M | $47M | $53M | $53M | $55M | $56M | $60M | $63M | $62M | $64M | $64M | $59M | $80M | $69M | $73M | $75M | |
| Common Stock | $11.0K | $10.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $8.0K | $8.0K | $6.0K | $6.0K | $6.0K | $6.0K | |
| Paid-in Capital | $744M | $724M | $719M | $712M | $709M | $705M | $701M | $693M | $689M | $684M | $668M | $664M | $525M | $504M | $500M | $496M | |
| Retained Earnings | $-646M | $-622M | $-597M | $-570M | $-542M | $-488M | $-448M | $-413M | $-378M | $-341M | $-299M | $-265M | $-255M | $-225M | $-197M | $-170M | |
| AOCI | $-71.0K | $-23.0K | $103.0K | $93.0K | $40.0K | $167.0K | $255.0K | $789.0K | $-319.0K | $-322.0K | $30.0K | $-981.0K | $-1M | $-730.0K | $-2M | $-2M | |
| Stockholders' Equity | $98M | $102M | $122M | $142M | $166M | $217M | $253M | $281M | $310M | $343M | $368M | $398M | $269M | $278M | $301M | $324M | |
| Liabilities + Equity | $143M | $149M | $175M | $195M | $221M | $274M | $313M | $344M | $373M | $407M | $432M | $458M | $350M | $347M | $374M | $399M | |
| Shares Outstanding | 105,995,653 | 96,951,234 | 95,143,690 | 93,468,038 | 93,123,239 | 93,004,602 | 92,378,577 | 90,552,687 | 90,362,771 | 90,314,501 | 88,448,948 | 88,430,609 | 66,100,039 | 61,323,523 | 61,029,184 | 60,986,936 |
Flux de trésorerie
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $625.0K | $649.0K | $682.0K | $631.0K | $1M | $1M | $1M | $1M | $856.0K | $710.0K | $740.0K | $2M | $617.0K | $589.0K | $506.0K | $450.0K | |
| Stock-based Comp | $2M | $2M | $3M | $3M | $3M | $4M | $4M | $4M | $5M | $4M | $4M | $3M | $4M | $3M | $3M | $3M | |
| Restructuring | · | · | · | · | · | · | · | $600.0K | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $-5M | · | · | · | $-2M | · | · | · | $-667.0K | · | · | · | · | · | · | |
| Operating Cash Flow | $-23M | $-27M | $-21M | $-25M | $-28M | $-37M | $-35M | $-33M | $-33M | $-37M | $-21M | $-29M | $-15M | $-28M | $-25M | $-22M | |
| CapEx | $1.0K | $72.0K | $-216.0K | $115.0K | $418.0K | $1M | $518.0K | $673.0K | $2M | $1M | $2M | $5M | $3M | $2M | $2M | $1M | |
| Investing Cash Flow | $19M | $24M | $18M | $11M | $24M | $49M | $16M | $27M | $21M | $23M | $-31M | $-68M | $11M | $21M | $1M | $-8M | |
| Stock Issued | $18M | $2M | $4M | $0 | $0 | $0 | $4M | $0 | $0 | $11M | $0 | $-1.0K | $-115.0K | $1M | $0 | $0 | |
| Net Stock Activity | · | $2M | · | · | · | $0 | · | · | · | $11M | · | · | · | · | · | · | |
| Financing Cash Flow | $18M | $3M | $4M | $277.0K | $6.0K | $468.0K | $4M | $244.0K | $132.0K | $12M | $-43.0K | $135M | $18M | $2M | $127.0K | $654.0K | |
| Net Change in Cash | $14M | $-303.0K | $1M | $-14M | $-4M | $13M | $-16M | $-6M | $-12M | $-2M | $-53M | $38M | $13M | $-6M | $-24M | $-30M | |
| Taxes Paid | · | · | · | · | · | · | · | $0 | · | · | $0 | $0 | · | · | $0 | $0 | |
| Free Cash Flow | · | $-27M | · | · | · | $-38M | · | · | · | $-39M | · | · | · | · | · | · |
Rentabilité
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1690.4% | -1096.4% | · | -1337.6% | -1784.0% | -1823.8% | · | -1889.2% | -1255.8% | -1893.9% | · | -61.8% | · | · | · | -803.4% | |
| Net Margin | -1619.9% | -1046.5% | · | -1253.3% | -2028.4% | -1699.6% | · | -1713.6% | -1088.2% | -1697.6% | · | -42.3% | · | · | · | -806.8% | |
| EBITDA Margin | -1690.4% | -1069.3% | · | -1337.6% | -1784.0% | -1774.2% | · | -1889.2% | -1255.8% | -1864.6% | · | -61.8% | · | · | · | -803.4% | |
| ROA | -13.4% | -11.9% | · | -10.2% | -18.2% | -11.8% | · | -8.6% | -10.4% | -10.9% | · | -2.3% | · | · | · | -6.2% | |
| ROE | -18.4% | -15.7% | · | -13.0% | -22.7% | -14.3% | · | -10.2% | -13.0% | -13.3% | · | -2.8% | · | · | · | -7.3% |
Liquidité et Solvabilité
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.5 | 6.2 | · | 5.5 | 6.7 | 7.6 | · | 7.4 | 8.8 | 10.5 | · | 14.3 | · | · | · | 10.7 | |
| Quick Ratio | 1.5 | 0.6 | · | 0.4 | 0.9 | 1.0 | · | 1.0 | 1.2 | 1.7 | · | 4.3 | · | · | · | 2.9 |
Efficacité
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | · | · | · | 0.0 | |
| Receivables Turnover | 10.9 | 15.2 | · | 10.3 | 18.7 | 4.7 | · | 3.1 | 7.1 | 2.0 | · | 30.9 | · | · | · | 6.8 |
Par action
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.93 | $1.05 | · | $1.52 | $1.78 | $2.34 | · | $3.11 | $3.44 | $3.80 | · | $4.50 | · | · | · | $5.31 | |
| Revenue / Share | $0.01 | $0.03 | · | $0.02 | $0.03 | $0.03 | · | $0.02 | $0.04 | $0.03 | · | $0.28 | · | · | · | $0.05 | |
| Cash Flow / Share | · | $-0.28 | · | · | · | $-0.40 | · | · | · | $-0.42 | · | · | · | · | · | · | |
| Cash / Share | $0.25 | $0.12 | · | $0.12 | $0.27 | $0.32 | · | $0.35 | $0.42 | $0.55 | · | $1.18 | · | · | · | $1.35 | |
| EPS (TTM) | $-1.08 | $-1.42 | · | $-1.70 | $-1.78 | $-1.62 | · | $-1.58 | $-1.32 | $-1.38 | · | $-1.50 | $-1.82 | $-1.66 | · | $-1.11 |
Valorisation (TTM)
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $10M | $11M | · | $9M | $9M | $10M | · | $11M | $33M | $33M | · | $35M | $15M | $14M | · | $13M | |
| Net Income TTM | $-103M | $-133M | · | $-157M | $-164M | $-148M | · | $-148M | $-123M | $-115M | · | $-95M | $-111M | $-100M | · | $-91M | |
| Market Cap | $187M | $184M | · | $218M | $117M | $85M | · | $177M | $148M | $464M | · | $423M | · | · | · | $643M | |
| P/E | -1.6 | -1.3 | · | -1.4 | -0.7 | -0.6 | · | -1.2 | -1.2 | -3.7 | · | -3.2 | -2.3 | -3.2 | · | -9.5 | |
| P/S | 18.6 | 16.4 | · | 23.4 | 12.9 | 8.6 | · | 15.5 | 4.5 | 13.9 | · | 12.2 | · | · | · | 50.6 | |
| P/B | 1.9 | 1.8 | · | 1.5 | 0.7 | 0.4 | · | 0.6 | 0.5 | 1.4 | · | 1.1 | · | · | · | 2.0 | |
| P / Tangible Book | 1.9 | 1.8 | · | 1.5 | 0.7 | 0.4 | · | 0.6 | 0.5 | 1.4 | · | 1.1 | 1.0 | 1.2 | · | 2.0 | |
| P / Cash Flow | · | -6.8 | · | · | · | -2.3 | · | · | · | -12.5 | · | · | · | · | · | · | |
| Earnings Yield | -61.4% | -74.7% | · | -73.0% | -141.3% | -177.4% | · | -80.6% | -80.5% | -26.9% | · | -31.4% | -42.8% | -31.3% | · | -10.5% |
Période la plus récente à gauche · valeurs nulles affichées comme ·
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
| Métrique | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenu | $11M | $10M | $34M | $14M | $10M |
| Marge d'exploitation % | -1329.4% | -1667.2% | -336.6% | -768.2% | -697.8% |
| Résultat net | $-148M | $-149M | $-102M | $-99M | $-67M |
| BPA dilué | $-1.59 | $-1.65 | $-1.38 | $-1.64 | $-2.11 |
| Métrique | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio de liquidité | 5.7 | 7.2 | 12.0 | 9.3 | 15.1 |
| Ratio de liquidité réduite | 0.5 | 0.5 | 1.8 | 2.1 | 9.4 |
| Métrique | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $-112M | $-143M | $-105M | $-97M | $-35M |
Détenteurs institutionnels (13F) 153 déclarants · $89.6M total · Au 30 septembre 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Détenteurs
153
Valeur détenue
$89.6M
Nouvelles positions
26
Positions clôturées
22
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 26 (-4 vs T. préc.) | 22 (+11 vs T. préc.) | 45 (+14 vs T. préc.) | 28 (-10 vs T. préc.) | +10.5M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| BlackRock, Inc. | $13 755 883 | 7 815 843 | 15,35% | Actions |
| Pfizer Inc | $7 879 924 | 4 690 431 | 8,79% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $7 407 080 | 4 208 568 | 8,27% | Actions |
| VANGUARD GROUP INC | $6 843 676 | 4 304 198 | 7,64% | Actions |
| MACKENZIE FINANCIAL CORP | $6 425 401 | 3 650 796 | 7,17% | Actions |
| RENAISSANCE TECHNOLOGIES LLC | $4 881 439 | 2 773 545 | 5,45% | Actions |
| Kynam Capital Management, LP | $4 405 812 | 2 503 302 | 4,92% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $4 180 624 | 2 374 894 | 4,66% | Actions |
| STATE STREET CORP | $2 873 929 | 1 632 914 | 3,21% | Actions |
| BANK OF AMERICA CORP /DE/ | $2 483 287 | 1 410 958 | 2,77% | Actions |
| TWO SIGMA INVESTMENTS, LP | $1 841 451 | 1 046 279 | 2,05% | Actions |
| TWO SIGMA ADVISERS, LP | $1 773 963 | 1 115 700 | 1,98% | Actions |
| DIMENSIONAL FUND ADVISORS LP | $1 716 629 | 975 327 | 1,92% | Actions |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1 365 424 | 775 809 | 1,52% | Actions |
| FMR LLC | $1 279 722 | 727 115 | 1,43% | Actions |
| NORTHERN TRUST CORP | $1 254 819 | 712 965 | 1,40% | Actions |
| MAVERICK CAPITAL LTD | $1 148 474 | 652 542 | 1,28% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 080 290 | 613 801 | 1,21% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $1 067 243 | 606 388 | 1,19% | Actions |
| Qube Research & Technologies Ltd | $960 529 | 545 755 | 1,07% | Actions |
| UBS Group AG | $910 573 | 517 371 | 1,02% | Actions |
| 72 Investment Holdings, LLC | $834 358 | 474 067 | 0,93% | Actions |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $723 323 | 410 979 | 0,81% | Actions |
| Green Alpha Advisors, LLC | $700 335 | 551 445 | 0,78% | Actions |
| MARSHALL WACE, LLP | $661 205 | 375 686 | 0,74% | Actions |
| PFM Health Sciences, LP | $624 249 | 354 687 | 0,70% | Actions |
| GOLDMAN SACHS GROUP INC | $568 260 | 322 875 | 0,63% | Actions |
| Invesco Ltd. | $529 966 | 301 117 | 0,59% | Actions |
| WELLS FARGO & COMPANY/MN | $525 035 | 298 315 | 0,59% | Actions |
| XTX Topco Ltd | $473 716 | 269 157 | 0,53% | Actions |
| Bruce & Co., Inc. | $440 000 | 250 000 | 0,49% | Actions |
| Man Group plc | $422 516 | 240 066 | 0,47% | Actions |
| Bank of New York Mellon Corp | $391 706 | 222 560 | 0,44% | Actions |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $305 140 | 173 375 | 0,34% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $291 129 | 165 414 | 0,32% | Actions |
| Susquehanna Portfolio Strategies, LLC | $279 131 | 158 597 | 0,31% | Actions |
| Graham Capital Management, L.P. | $274 409 | 155 914 | 0,31% | Actions |
| MILESTONE ASSET MANAGEMENT, LLC | $257 433 | 202 703 | 0,29% | Actions |
| AMERICAN CENTURY COMPANIES INC | $247 421 | 140 580 | 0,28% | Actions |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $232 320 | 132 000 | 0,26% | Actions |
| Nuveen, LLC | $217 388 | 123 516 | 0,24% | Actions |
| CITADEL ADVISORS LLC | $217 008 | 123 300 | 0,24% | Option d'achat |
| Cubist Systematic Strategies, LLC | $216 135 | 92 762 | 0,24% | Actions |
| LPL Financial LLC | $216 082 | 122 774 | 0,24% | Actions |
| MORGAN STANLEY | $213 523 | 121 320 | 0,24% | Actions |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $206 800 | 117 500 | 0,23% | Actions |
| DEUTSCHE BANK AG\ | $157 652 | 89 575 | 0,18% | Actions |
| Quadrature Capital Ltd | $156 603 | 88 979 | 0,17% | Actions |
| CANADA PENSION PLAN INVESTMENT BOARD | $142 736 | 81 100 | 0,16% | Actions |
| Keystone Financial Group | $142 252 | 80 825 | 0,16% | Actions |
Activistes et détenteurs de 5%+ 1 participation
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| The City Canyon Family Trust dated May 31, 2021, Rachel E. Haurwitz, Felix Adler ×3 dépôts | 25 avril 2025 | 5,00% | Dépôt initial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Initiés de la société 18 initiés · 9 dirigeants · 7 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Rachel E. Haurwitz | President and CEO | 20 février 2026 A | 447 150 | 0 | 0 | $0 |
| Sriram Ryali | Chief Financial Officer | 20 février 2026 A | 72 360 | 0 | 0 | $0 |
| Jason O'Byrne | Chief Financial Officer | 20 février 2024 A | 59 224 | 0 | 0 | $0 |
| Timothy P Kelly | Chief Technology Officer | 25 février 2026 S | 73 125 | 0 | 2 | $-18 188 |
| Tina M. Albertson | Chief Medical Officer | 20 février 2026 A | 68 523 | 0 | 1 | $-2 089 |
| Ruhi Ahmad Khan | Chief Business Officer | 20 février 2026 A | 104 998 | 0 | 1 | $-13 598 |
| Steven Kanner | Chief Scientific Officer | 20 février 2025 A | 431 556 | 0 | 0 | $0 |
| Ryan Fischesser | VP of Finance and Controller | 20 novembre 2024 A | 118 854 | 0 | 0 | $0 |
| Syed Ali-Aamir Rizvi | Chief Medical Officer | 21 février 2023 A | 59 373 | 0 | 0 | $0 |
| Dara Richardson-Heron | Administrateur | 20 février 2026 A | · | 0 | 0 | $0 |
| Ran Zheng | Administrateur | 20 février 2026 A | · | 0 | 0 | $0 |
| Nancy Whiting | Administrateur | 20 février 2026 A | · | 0 | 0 | $0 |
| David Lee Johnson | Administrateur | 20 février 2026 A | · | 0 | 0 | $0 |
| Natalie Sacks | Administrateur | 20 février 2026 A | · | 0 | 0 | $0 |
| Scott Braunstein | Administrateur | 20 février 2026 A | · | 0 | 0 | $0 |
| Barbara G Mcclung | · | 20 février 2026 A | 481 564 | 0 | 1 | $-13 598 |
| Andrew Guggenhime | · | 20 février 2026 A | · | 0 | 0 | $0 |
| FMR LLC | · | 27 juillet 2021 C | 1 464 775 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Détention d'ETF Détenu par 15 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,03% | 164 883 SH | 23 octobre 2026 | Quotidien |
| IWC · iShares Trust | 0,03% | 319 257 SH | 11 septembre 2026 | Quotidien |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 79 869 SH | 19 août 2026 | Quotidien |
| IBB · iShares Trust | 0,01% | 670 052 SH | 11 septembre 2026 | Quotidien |
| RSSL · Global X Funds | 0,00% | 43 883 NS | 31 juillet 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 2 250 647 SH | 11 septembre 2026 | Quotidien |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,00% | 7 395 SH | 23 octobre 2026 | Quotidien |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,00% | 130 838 SH | 23 octobre 2026 | Quotidien |
| DFAS · Dimensional ETF Trust | 0,00% | 255 338 NS | 31 juillet 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 74 931 NS | 31 juillet 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 1 113 215 SH | 19 août 2026 | Quotidien |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 3 013 973 SH | 19 août 2026 | Quotidien |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 524 917 SH | 19 août 2026 | Quotidien |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 9 015 SH | 19 août 2026 | Quotidien |
| IWN · iShares Trust | · | 875 712 SH | 11 septembre 2026 | Quotidien |
CRBU Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
notation · 13 analystes
ACHAT
Objectif médian
$4.50
+868,2%
5 38,5%
Achat fort
7 53,8%
Achat
1 7,7%
Conserver
0 0,0%
Vente
0 0,0%
Vente forte
Objectif de cours à 12 mois
4 analystes · 2026-10-23Objectif moyen $5.75 +1137,1%
← En dessous de tous les objectifs
Prix actuel $0.46
Bas$1.00
Moyenne$5.75
Haut$13.00
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
Base F.A., prix à la clôture de la dernière fin d'exercice de chaque société.
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| CRBU | $151M | -1.0 | 11.7% | -1327.4% | -102.8% | · |
| CNTB | $159M | -2.8 | -99.8% | -86687.5% | -97.9% | · |
| GANX | $135M | -5.3 | -60.6% | · | -181.1% | · |
| HOWL | $31M | -0.5 | · | · | -183.6% | · |
| XLO | $3M | -0.2 | 589.9% | -80.0% | -165.5% | · |
| IBIO | $97M | -5.5 | -75.0% | -33044.0% | -65.7% | · |
| BMEA | $90M | -1.1 | -67.1% | -3326.0% | -216.6% | · |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
Choisissez les indicateurs qui vous importent — cliquez sur le + à côté de n'importe quelle ligne dans les Fondamentaux complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Source : Dépôt SEC 10-Q le Aoû 13, 2026